Mesoporous silica nanoparticles as anticancer drug carriers in pancreatic cancer treatment
Pancreatic cancer, often referred to as “the silent killer”, presents with minimal or no symptoms in its early stages, resulting in late detection. When surgical resection is no longer the optimal treatment option, chemotherapy becomes crucial at this stage. However, the low 5-year survival rate hig...
| Main Author: | |
|---|---|
| Format: | Thesis (University of Nottingham only) |
| Language: | English |
| Published: |
2025
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/80216/ |